J Neurol Neurosurg Psychiatry 77:1296-1297 doi:10.1136/jnnp.2006.090639
  • Letter

Novel Olig 1-coding variants and susceptibility to multiple sclerosis

  1. A Goris,
  2. T W Yeo,
  3. M Maranian,
  4. A Walton,
  5. M Ban,
  6. J Gray,
  7. A Compston,
  8. S Sawcer
  1. Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
  1. Correspondence to:
 A Goris
 Department of Clinical Neurosciences, Neurology Unit, Box 165, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; ag441{at}
  • Accepted 27 June 2006
  • Published Online First 4 July 2006

Olig1 is a basic helix–loop–helix (bHLH) transcription factor expressed in cells of the oligodendrocyte lineage in the nervous system. Its role during normal development has not yet been fully resolved, but it is known that in adult life the protein is crucial in the process of remyelination after injury.1–3 Olig1 translocates from the cytoplasm to the nucleus in early remyelinating lesions in rodent models of demyelinating disease as well as in oligodendrocyte precursor cells at the edge of multiple sclerosis lesions.1 Olig1 specifically regulates the expression of the major myelin-specific genes during oligodendrocyte maturation in the brain,2 and remyelination after injury is impaired in Olig1-/- mice.1 In patients with multiple sclerosis, remyelinating capacity is limited even though oligodendrocyte precursor cells are often efficiently recruited.4 These findings raise the question whether genetic variants in the Olig1 gene (Olig1) influence remyelinating capacity and vulnerability to …

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article